Publications

Export 1930 results:
Auteur [ Title(Desc)] Type Année
Filtres: Filter is   [Enlever les filtres]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Pascoal TA, Mathotaarachchi S, Shin M, Park AYeon, Mohades S, Benedet AL, Kang MSu, Massarweh G, Soucy J-P, Gauthier S et al..  2018.  Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 45(6):1021-1030.
Pascoal TA, Mathotaarachchi S, Mohades S, Benedet AL, Chung C-O, Shin M, Wang S, Beaudry T, Kang MS, Soucy J-P et al..  2016.  Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.. Mol Psychiatry.
Silva PNatalia, Furuya TKatsue, Braga ILacerda, Rasmussen LTrevizani, Labio RWillian, Bertolucci PHenrique, Chen ESuchi, Turecki G, Mechawar N, Payão SLuiz et al..  2014.  Analysis of HSPA8 and HSPA9 mRNA expression and promoter methylation in the brain and blood of Alzheimer's disease patients.. J Alzheimers Dis. 38(1):165-70.
Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R et al..  2018.  Analysis of shared heritability in common disorders of the brain.. Science. 360(6395)
Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K et al..  2018.  Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.. Front Psychiatry. 9:207.
Ongali B, Nicolakakis N, Tong X-K, Aboulkassim T, Papadopoulos P, Rosa-Neto P, Lecrux C, Imboden H, Hamel E.  2014.  Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.. Neurobiol Dis. 68:126-36.
Therriault J, Ng KPin, Pascoal TA, Mathotaarachchi S, Kang MSu, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V et al..  2018.  Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.. Neurology. 90(11):e932-e939.
Rifkin-Graboi A, Meaney MJ, Chen H, Bai J, Hameed WBak'r, Tint MThway, Broekman BFP, Chong Y-S, Gluckman PD, Fortier MV et al..  2015.  Antenatal maternal anxiety predicts variations in neural structures implicated in anxiety disorders in newborns.. J Am Acad Child Adolesc Psychiatry. 54(4):313-21.e2.
Orrico-Sanchez A, Chausset-Boissarie L, de Sousa RAlves, Coutens B, Amin SRezai, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T et al..  2019.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.. Mol Psychiatry.
Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JPablo, Grenier J, Ibrahim EChérif, Khoury M-AEl, Tse YC, Mongredien R et al..  2018.  Antidepressive effects of targeting ELK-1 signal transduction.. Nat Med. 24(5):591-597.
Kieffer BL.  2019.  An Anti-Opioid System, Courtesy of a Worm Model.. N Engl J Med. 381(21):2067-2069.
Freire ACarlos Cru, Pondé MPereira, Liu A, Caron J..  2017.  Anxiety and Depression as Longitudinal Predictors of Mild Cognitive Impairment in Older Adults.. Can J Psychiatry. 62(5):343-350.
Chong S-C, Broekman BFp, Qiu A, Aris IM, Chan YHuak, Rifkin-Graboi A, Law E, Chee CYin Ing, Chong Y-S, Kwek KYC et al..  2016.  ANXIETY AND DEPRESSION DURING PREGNANCY AND TEMPERAMENT IN EARLY INFANCY: FINDINGS FROM A MULTI-ETHNIC, ASIAN, PROSPECTIVE BIRTH COHORT STUDY.. Infant Ment Health J. 37(5):584-98.
King NMA, Chambers J, O'Donnell K, Jayaweera SR, Williamson C, Glover VA.  2010.  Anxiety, depression and saliva cortisol in women with a medical disorder during pregnancy.. Arch Womens Ment Health. 13(4):339-45.
Baer LH, Shah JL, Lepage M.  2019.  Anxiety in youth at clinical high risk for psychosis: A case study and conceptual model.. Schizophr Res. 208:441-446.
Roy É, Jutras-Aswad D, Bertrand K, Dufour M, Perreault M, Laverdière É, Bene-Tchaleu F, Bruneau J.  2015.  Anxiety, mood disorders and injection risk behaviors among cocaine users: Results from the COSMO study.. Am J Addict. 24(7):654-60.
Deschênes SS, Burns RJ, Schmitz N.  2016.  Anxiety symptoms and functioning in a community sample of individuals with type 2 diabetes: A longitudinal study.. J Diabetes. 8(6):854-862.
Albaugh MD, Ducharme S, Karama S, Watts R, Lewis JD, Orr C, Nguyen T-V, Mckinstry RC, Botteron KN, Evans AC et al..  2016.  Anxious/depressed symptoms are related to microstructural maturation of white matter in typically developing youths.. Dev Psychopathol. :1-8.
Grizenko N, Eberle MLoren, Fortier M-È, Côté-Corriveau G, Jolicoeur C, Joober R.  2016.  Apgar Scores Are Associated with Attention-Deficit/Hyperactivity Disorder Symptom Severity.. Can J Psychiatry. 61(5):283-90.
Ba M, Kong M, Li X, Ng KPin, Rosa-Neto P, Gauthier S.  2016.  Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease? Transl Neurodegener. 5:20.
Konishi K, Bhat V, Banner H, Poirier J, Joober R, Bohbot VD.  2016.  APOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus.. Front Hum Neurosci. 10:349.
Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner JCS, Dea D.  2014.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.. Neurobiol Aging. 35 Suppl 2:S3-10.
Lajoie I, Nugent S, Debacker C, Dyson K, Tancredi FB, Badhwar AP, Belleville S, Deschaintre Y, Bellec P, Doyon J et al..  2017.  Application of calibrated fMRI in Alzheimer's disease.. Neuroimage Clin. 15:348-358.
Gariépy G, McIlwaine SV, Schmitz N, Shah JL.  2018.  An approach to sample size calculation for research on duration of untreated psychosis.. Schizophr Res.
Villeneuve S, Wirth M, La Joie R.  2015.  Are AD-Typical Regions the Convergence Point of Multiple Pathologies? Front Aging Neurosci. 7:42.

Pages